President Donald Trump signed a new executive order aimed at aligning U.S. drug prices with those of other countries by removing private-sector middlemen from the system. While the move caused a drop in stocks, it promises significant changes for the pharmaceutical industry.
President Donald Trump took a significant step to address rising drug costs in the U.S. on Monday by signing an executive order aimed at removing private-sector middlemen from the pricing process. This move is designed to align American drug prices with those in other countries, which pay considerably less for the same medications.
The new order seeks to directly connect pharmaceutical companies with U.S. consumers, bypassing the intermediaries who often inflate costs through hidden discounts and administrative fees. In a press conference, Trump stated, "We’re going to cut out the middlemen and facilitate the direct sale of drugs at the most favored nation price, directly to the American citizen."
The United States currently pays about three times more for prescription drugs than other nations. Under the executive order, pharmaceutical companies will be required to charge similar prices in both the U.S. and Europe. Additionally, the U.S. Department of Health will establish a system that allows patients to purchase medications directly from manufacturers, potentially lowering costs significantly.
Pharmaceutical Stocks See Volatility
The announcement sent shockwaves through the stock market. Shares of major pharmacy benefit managers (PBMs) — CVS Health, UnitedHealth Group, and Cigna — all saw declines, with CVS down 5%, UnitedHealth dropping 0.5%, and Cigna falling 6%. These companies manage prescription drug plans for millions of Americans through their pharmacy benefit manager subsidiaries, Caremark, Optum Rx, and Express Scripts, respectively.
PBMs have long been under scrutiny for their role in driving up drug prices. The Federal Trade Commission (FTC) has already applied regulatory pressure on these firms, particularly over their pricing practices for insulin. Critics argue that PBMs’ hidden fees and rebates contribute to the high costs of medications by obscuring the true price consumers pay.
Pharmaceutical Industry Responds
While the pharmaceutical industry has placed much of the blame on PBMs for inflated prices, industry representatives stress that the real issue lies with drug manufacturers. Greg Lopes, Vice President of Public Affairs at the Pharmaceutical Care Management Association, argued that PBMs are essential in counteracting the pricing power of drug companies.
CVS, in a statement, welcomed Trump’s focus on drug pricing and emphasized its willingness to work with the administration to make medications more affordable. The company also pointed out that its negotiations with drugmakers have resulted in significantly lower costs for prescription drugs, especially for Medicare beneficiaries, compared to prices set by the government.
Cigna and UnitedHealth did not respond immediately to requests for comment.
Challenges in Implementation
Despite the potential benefits, analysts caution that implementing these changes may face significant hurdles. One of the biggest challenges is the U.S. reliance on employer-sponsored health plans, which could complicate the direct purchase of medications by consumers. Julie Utterback, an analyst at Morningstar, noted that PBMs provide bundled services to their clients, and companies could raise the costs of other services to offset the impact of lower drug prices.
Utterback also pointed out that UnitedHealth, which is more diversified than CVS and Cigna, saw less of a stock decline because its business model is not as heavily reliant on retail pharmacy operations. CVS, on the other hand, could face challenges from reduced prices on prescription medications.
The administration’s focus on lowering drug prices is not without controversy. While the move has been welcomed by consumers and some industry players, it is likely to face resistance in Congress and from stakeholders who fear it could disrupt existing business models.
Global investors are bracing for significant market turmoil when trading reopens, with analysts predicting a sharp spike in oil prices and a flight to safe-haven assets following the United States' announcement of military strikes against three Iranian nuclear facilities.
Iran’s top diplomat on Sunday issued a stark condemnation of the United States following overnight military strikes on Iranian nuclear facilities, declaring that Washington had crossed a "very big red line" and would be held "fully responsible" for the consequences.
A chorus of condemnation emerged from Latin America on Sunday as leaders from Chile, Cuba, Venezuela, Colombia, and Bolivia denounced the United States for its recent airstrikes on three Iranian nuclear facilities.
The United States' military strike on three Iranian nuclear facilities Sunday triggered sharply divided reactions from the international community, with Israel lauding the move as a historic decision while Iran, the United Nations, and numerous other nations condemned the attack.
Start your day informed with AnewZ Morning Brief: here are the top news stories for June 22nd, covering the latest developments you need to know.
Global investors are bracing for significant market turmoil when trading reopens, with analysts predicting a sharp spike in oil prices and a flight to safe-haven assets following the United States' announcement of military strikes against three Iranian nuclear facilities.
Iran’s top diplomat on Sunday issued a stark condemnation of the United States following overnight military strikes on Iranian nuclear facilities, declaring that Washington had crossed a "very big red line" and would be held "fully responsible" for the consequences.
A chorus of condemnation emerged from Latin America on Sunday as leaders from Chile, Cuba, Venezuela, Colombia, and Bolivia denounced the United States for its recent airstrikes on three Iranian nuclear facilities.
The United States' military strike on three Iranian nuclear facilities Sunday triggered sharply divided reactions from the international community, with Israel lauding the move as a historic decision while Iran, the United Nations, and numerous other nations condemned the attack.
Start your day informed with AnewZ Morning Brief: here are the top news stories for June 22nd, covering the latest developments you need to know.
Iranian missiles struck multiple locations across Israel and neighbouring regions early Friday morning, including a Microsoft office complex, according to emergency responders and local media reports.
A high-speed tram derailment in central Gothenburg, Sweden, has left at least eight people injured late on Thursday (19 June), after the vehicle slammed into a snack bar on Avenyn Avenue.
China has unveiled a mosquito-sized bionic drone designed for covert military operations and battlefield reconnaissance, marking a major advance in micro-robotics and stealth technology as part of the country’s growing focus on next-generation warfare capabilities.
The 2025 G7 Leaders’ Summit was held June 15–17 in Kananaskis, Alberta, under Canada’s presidency. Prime Minister Mark Carney framed the meeting around priorities of protecting communities, energy and climate security, the digital transition, and future partnerships.
The USS Nimitz is heading to the Middle East amid tensions between Israel and Iran. The U.S. aircraft carrier has a decades-long history in the region, from the 1979 hostage crisis to modern deployments, often serving as a key asset during periods of rising friction with Iran.
The world is facing a health financing emergency as global health investment risks falling to its lowest level in a decade, the World Health Organization (WHO) warned.
China has successfully mastered the technology to produce Yttrium-90, a critical medical isotope used in radiation therapy for liver cancer, within a commercial nuclear reactor.
German biotech firm BioNTech (22UAy.DE), has agreed to acquire domestic peer CureVac, for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.
Revolutionizing Heart Care: How Artificial Intelligence Powered Digital Twins Are Shaping the Future of Medicine
Researchers at the University of Miami have discovered 230 new giant viruses in global ocean waters, shedding light on their hidden role in marine ecosystems and their potential impact on public health.
Global investors are bracing for significant market turmoil when trading reopens, with analysts predicting a sharp spike in oil prices and a flight to safe-haven assets following the United States' announcement of military strikes against three Iranian nuclear facilities.
Iran’s top diplomat on Sunday issued a stark condemnation of the United States following overnight military strikes on Iranian nuclear facilities, declaring that Washington had crossed a "very big red line" and would be held "fully responsible" for the consequences.
A chorus of condemnation emerged from Latin America on Sunday as leaders from Chile, Cuba, Venezuela, Colombia, and Bolivia denounced the United States for its recent airstrikes on three Iranian nuclear facilities.
The United States' military strike on three Iranian nuclear facilities Sunday triggered sharply divided reactions from the international community, with Israel lauding the move as a historic decision while Iran, the United Nations, and numerous other nations condemned the attack.
Start your day informed with AnewZ Morning Brief: here are the top news stories for June 22nd, covering the latest developments you need to know.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment